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Abstract-Pediatric Acquired lmmunodeficiency Syndrome (AIDS) is expected to increase 
by greater than 75% by 1993. Most of these infants will become infected with the Human 
lmmunodeficiency Virus (HIV) through the mother. It is unclear exactly how the virus is passed 
from mother to child. The nature of HIV infection is described in this paper, and several 
mechanisms relevant to its transfer are proposed. 
As the number of persons in the US diagnosed with 
AIDS passes 200 000, (1) an increasing number rep- 
resent infants infected either ‘in utero’ or soon after 
birth. Pediatric AIDS constitutes approximately 1 .l% 
of all AIDS cases; there has been a 46% escalation in 
pediatric AIDS cases reported since 1989. It is pro- 
jected that from 1990 to 1993 the number of pedi- 
atric AIDS cases will increase by 75-85% (2). Thus, 
pediatric AIDS exemplifies a medical concern which 
needs to be addressed separately from a broad spec- 
trum of infectious diseases. 
The number of AIDS/HIV infected women of 
childbearing age worldwide has been estimated as 1 
505 000 (3, 4). In the US, women currently repre- 
sent 11% of all AIDS cases diagnosed in adults. The 
increase in the number of HIV infected women indi- 
cates that a higher percentage of infants will become 
infected with HIV, since 85% of HIV infected women 
in the US are between 15 and 44 years of age (2). 
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Description of HIV 
HIV is a retrovirus of the lentivirinae subfamily. 
These viruses are characterized by a diploid RNA 
genome, neurotropic behavior, and a long latent pe- 
riod. Infection of the cell begins when the surface gly- 
coprotein (gp 120) of the HIV attaches to the CD4 re- 
ceptor of the appropriate cell, and the viral glycopro- 
tein gp41 fuses with the cell membrane. The ribonu- 
cleic acid is transformed or transcribed into a deoxyri- 
bonucleic acid by a viral enzyme known as an RNA- 
directed DNA polymerase (reverse transcriptase). The 
transcription occurs within the cytoplasm of the cell, 
but the transcribed RNA is transferred into the nu- 
cleus of a cell, and joined with the host cell’s chromo- 
somes. The virus may become dormant in the cell or 
may undergo replication. The CD4+ cells which the 
HIV attacks include T-lymphocytes, primarily the T4 
helper cells (T4), cells of the monocyte-macrophage 
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lineage, glial cells of the central nervous system, and 
the chromaffin cells of the gastrointestinal tract. In- 
f&on of the chromaffin and glial cell may result 
in severe diarrhea and neuropathy which often ac- 
companies HIV infection. The primary role of the 
CD4+ T helper cell in immunity is to stimulate im- 
munoglobin secretion by B-lymphocytes, and to in- 
duce other classes of T-cells to proliferate. Non-nal 
levels range from 1000-1500 CD4+ cells per cubic 
millimeter, while in patients diagnosed with AIDS, 
levels drop below 200 (5). This loss of T-helper cells 
results in a profound immunodeficiency. 
HIV infection among adult women 
Women are primarily infected by HIV through one of 
three major transmission routes: 1) intravenous drug 
use 2) through sexual intercourse with an intravenous 
drug user, or, in previous years, 3) blood transfusi- 
ons. IV drug abuse is currently the major route by 
which women become infected (5 1% of HIV infected 
women). 33% of HIV infected women have acquired 
the virus via heterosexual contact. Of these women, 
62% were infected through sexual encounters with IV 
drug users and 10% through sexual encounters with 
a bisexual male (Table 1). In most cases one or both 
of the partners had microscopic lesions which allowed 
HIV to enter through the epidermis via sperm or other 
genital and epidermal secretions. 
Risk behavior among HIV positive women 
58% of HIV infected females are Black, while 21% 
are Caucasian and 20% are Hispanic females. Of the 
women infected through sexual intercourse, 49% are 
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Black, 31% are Hispanic, and 20% are Caucasian 
(1). It has been suggested that the higher number of 
HIV cases in minorities is in part a function of their 
lower socioeconomic level. The ability to purchase 
contraceptive devices is often limited among women 
of minority groups because of their lower income 
(6). Female intravenous drug users often do not use 
contraceptive methods effectively. The use of heroin 
may eliminate or minimize the menses of the en- 
dometrium. Therefore, when female IV drug abusers 
recognize that their menses’ flow is eliminated, they 
may assume that they have become infertile. When 
engaging in heterosexual activity, women who carry 
out these risk behaviors may not use spermicidal jel- 
lies or creams (or inform their partner to use a con- 
dom, for a variety of reasons) because they assess 
that they are unable to conceive children. In many 
instances, the partner simply refuses to use a condom. 
Thus, the risk of infecting a child which has been con- 
ceived increases. Historically, the major contraception 
method used by female IV drug abusers has been the 
‘pill’ (7) which needs to be taken consecutively to 
serve as an effective deterrent against fertilization. 
However, the drug user may be disoriented because 
of her drug abuse; she may discontinue the pill med- 
ication. When she engages in sexual intercourse with 
an HIV carrier, fertilization is more likely to occur, 
and the probability of HIV infection of the fetus also 
increases. 
Expression of pediatric AIDS 
Pediatric AIDS is defined as a diagnosis in children 
less than 13 years of age. Between 1980 and April 
Table 1 Female exposure to HIV/human imrnunodeticiency syndrome* 
Number of women 
Exposure chss HIV-infected 
Intravenous DN~ Abuse 8537 (51%) 
Sexual contact 5534 (33%) 
- Sexual intercourse with IV dtug abuser 3451 (62%) 
- Sexual intercourse with an HIV-infected person 698 (13%) 
- Sexual intercourse with a bisexual male 540 (10%) 
Blood transfusion recipient 1496 (9%) 
Other 1238 (7%) 
a. Women are between 15 and 44 years of age. b. Other means of HIV infection via sexual intercourse are specified in the text. c. 
Blood transfusion is a means by which HIV is transferred through epidennal contact with the blood of an HIV-infected person or 
through a clinical transfusion. d. The term ‘other’ implies patients who refused to submit to questioning about their HIV-positive 
condition, who died, and who were not pursued for further information about their condition. * Adapted from Cerrkrs for Disease 
Control. HIV/AIDS Surveillance Report, April 1991; p 10. 
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1991,2963 pediatric AIDS cases have been reported, 
with 24 11 of these cases occurring in infants below 
the age of 5.54% of the HIV infected pediatric infants 
were male, while 46% of HIV infected pediatric in- 
fants were female. Black infants represent over half of 
pediatric AIDS cases, and Caucasian infants represent 
most of the remainder (Table 2). 
As indicated above, infants may be indirectly in- 
fected as a result of the mother’s risk behavior, (Table 
1). Infants who are born to HIV-positive, drug-abus- 
ing mothers generally are classified in the P-l group 
and usually develop immune abnormalities in early 
postpartum (fable 3). Exposing the fetus to intra- 
venous drugs may drop the lymphocyte count by as 
much as 46% below that normally found immediately 
after birth (9); life expectancy decreases because the 
immune system is less likely to resist infection. Al- 
though, at birth, HIV-negative infants possess higher 
numbers of TChelper cells than adults (5), the T-4 
helper cells in an IV drug exposed infant decrease 
by 30% when compared with a drug-free infant (8). 
One could suggest that the infant’s exposure to drugs 
such as methadone and heroin minimizes the effec- 
tiveness of the immune system, and if HIV infection 
occurs, the incubation period for HIV is drastically 
shortened (9). Infants placed in the class P-O may 
not be infected by HIV, but they possess antibody 
directed against HIV, acquired through the transfer of 
the maternal immunoglobin (IgG) across the placental 
membrane (10). 
Class P-l infants are infected with HIV, but they do 
not yet express P-2 symptoms of immunodeficiency. 
Nevertheless, the infant may express immunological 
abnormalities; increased levels of IgG are common. 
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Although it is highly probable that the infant’s lym- 
phatic system is responding to HIV infection, the high 
levels of antibodies may be induced by other infec- 
tious agents, or even result from the erection of the 
deciduous teeth. Immune abnormalities may also be 
manifested as a decreased ratio of the lymphocytes of 
T4 helper cells to T8 cytotoxic/suppressor cells (10, 
11). 
Infants classed as P-2 express symptoms of HIV 
infections as defined below. 
Subclass A infants express persistent fever, failure- 
to-thrive, and a loss of 10% or more of the in- 
fant’s weight (13). The weight loss may be caused 
by recurrent or persistent diarrhea, or by the lack 
of appetite which often accompanies a fever. Hep- 
atomegaly, splenomegaly, and lymphadenopathy also 
indicate unexplained manifestations of the HIV infec- 
tion. 
Subclass B infants express a neurological decline 
in the developmental plateaus: blinking, facial ges- 
tures, and verbal behavior. Abnormal ocular move- 
ments may be an earlier indication of HIV infection in 
P-O and P-l infants because the central nervous sys- 
tem is infected before immunodeficiency occurs (12). 
Exactly why this is the case is not known. One may 
conjecture that because the (IV) trochlear nerve is the 
thinnest of the 12 cranial nerves, it may be infected 
the earliest, and thereby become inoperative sooner 
than the other cranial nerves. Thus, impulses from 
the trochlear nerve to the superior oblique extrinsic 
ocular muscle may not induce the muscle to rotate 
and the infected infant ceases to rotate the eyeball in 
a downward lateral motion. Loss of head movement 
and a change in tone may indicate the deterioration of 
Table 2 Pediatric AIDS cases categorized by racial ethnic orientation* 
Caucasian Black 
non-Hispanic non-Hispanic Hispanic OlhUS 
Hemophilia-coagulation disorder 100(68%) 19113%) 24(16%) 3(2%) 
Parent at risk for HIV infection 391(16%) 1434 
- intravenous drug abuse 
642(26%) 15(-) 
189 703 328 4 
- sex with drug abuser 80 231 203 3 
Received blood transfusion 139 55 60 5 
Other 132 538 131 11 
a. Under age 13 at time of diagnosis. b. Assimilated up to April, 1991. c. African/Haitian/Jamaican-American. d. Asian American, 
Pacific-American, American-Indian, and Alaskan-American. e. Other risk factors of mothers include: 1) possess HIV b) birth in a 
pattern II country, 3) sexual intercourse. with an HIV infected person. 4) sexual intercourse with a bisexual male, 5) sexual encounters 
with a recipient of blood transfusion, 6) sexual encounter with a person born in a Pattern II (Jamaica, Haiti) country, 7) sexual 
encounter with hemophiliac, 8) undetermined risk factors. 
Report, April 1991. 
* Adapred from Centers for Dticase Control. HIV/AIDS Surveillance 
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Table 3 Classification of human immunodeficiency virus (HIV) pediatric cases* 
Class P-O. Indeterminate Infections The presence of HIV antibody in the infant’s bloodstream is the only indication of possible HIV 
infection. 
Class P-l. Unexplained HIV Infections Subclass A: The infant does nct express immune abnormalities even thwgh its mother possessed Hi\ 
Subclass B: Immune almonnalities occur: hypergammaglobulinemia, decreased T-helpern-suppressor 
cell ratio, and absolute lyrnphopenia. 
Subclass C: Infants may have been tested for Subclass B symptoms, but further testing was 
discontinued because the infant may not have been brought back to clinic for further testing. 
Class P-2. Clinical Manifestations of HIV Infants, who are diagnosed with physical symptoms caused by HIV, possess primarily Subclass P-O 
in Infants symptans. 
Subclass A: General physical signs for HIV infection. Children persist with a fever, failure-to- 
thrive, weight loss, hepatanegaly, splenomegaly. and Iymphadenopathy in which the lymph nodes 
increase in width to 0.5 cm or more. 
Subclass B: Neurological associated disorders with HIV. Motor control deteriorates, manifested 
through paresis, deeper or higher vocal tone, ataxis. and gait disturbance. 
Subclass C: Lymphoid interstitial pneumonitis (LIP). UP consists of extensive infiltration of the 
lungs with mononuclear cells. Pathogens are dismissed as possible causes of LIP Chronic bilateral 
reticulonodular infiltrates are visible from X-rays, and the presence of the infiltrates continues 
for 2 months or more. 
Subclass D: Infections directly linked to immunodeficiency. 
Category D-l: Patients suffer from a variety of opportunistic infectious disease which have been 
reported to the CDC. 
Category D-2: Infants have recurrent baceterial infections. 
Category D-3: Infants are infected with the dermal diseases such as oral candidiasis, herpes 
stomatitis, and herpes roster, 
Subclass E: HIV associated cancers. 
Category E-l: Infants are diagnosed with secondary cancers such as Kaposi’s sarcoma, B-cell non- 
Hodgkin’s lymphana, and neurological Iymphoma. 
Category E-2: Other cancers which occur as a secmdluy means to the HIV infection. 
Subclass F: Other manifestations. Other manifestations which occur may or may not be directly 
correlated with IIIV infection in infants. The CDC does nol currently place these 
symptans into categories, (hepatitis, cardiopathy, etc). 
* Centers for Disease Con&of. Classification System for Human Immunodeficiency Virus (HIV) Infection in children under 13 years 
of age MMWK. April 24, 1987; VoI 36, No 15: 225-230. 
the accessory (XI) nerve by HIV. Paresis, abnormal 
tone, ataxia, and gait disturbance are also common 
symptoms induced neurological deterioration. 
Subclass C infants suffer from Lymphoid Inter- 
stitial Pneumocystis (LIP). LIP is manifested as an 
upper respiratory infection, resulting in diffusion of 
lymphocytes and plasma cells through the bronchial 
lymphoid tissue. LIP occurs in approximately 40% 
of all HIV infected children, and is not known to 
he associated with parasitic infection (14). The syn- 
drome is often accompanied by parotid enlargement, 
and elevated levels of immunoglobins. The Mediasti- 
nal nodes may also become enlarged. 
Subclass D infants are diagnosed with infectious 
diseases as a direct result of HIV induced immun- 
odeficiency. Category D-l infants may develop a va- 
riety of syndromes, including Pneumocystis carinii 
pneumonia (PCP), chronic cryptosporidiosis, toxo- 
plasmosis, chronic isoporiasis, esophageal, bronchial, 
or pumonary candidiasis and cytomegalovirus infec- 
tions. Chronic herpes simplex may infect the cuta- 
neous layer of the mucous membranes of the buc- 
cal cavity. Nocardiosis, chronic leukoencephalopathy, 
and other opportunistic infections have also been re- 
ported by the CDC (10). PCP occurs in approximately 
70% of all HIV infected infants; approximately 64% 
MANIFESTATIONS OF PEDIAI-RIC AIDS 209 
of the infants who are diagnosed with acute PCP die HIV infected only when the immunoglobulin G levels 
from the infection (5). persist for 15 months or more (19). 
In an HIV infected adult, a CD4+ cell count above 
250 cells per cubic millimeter indicates that PCP has 
a 0.06% probability of occurrence. However, in HIV 
infected infants, there is a 6% chance that PCP may 
develop when the CD4+ cell count is above 250 (15). 
The CD4+ cell count may be higher in infants than in 
adults because there is an increase in T-lymphocytes 
production immediately after parturition. Within the 
first year, a clinically healthy infant’s CD4+ count is 
approximately 3500 cells per cubic millimeter, but it 
regresses to the range of 1500 and 2000 T-lympho- 
cytes by the age of two (5, 16). Because the infant is 
more susceptible to infection immediately after birth, 
the cortical cells of the thymus may induce an esca- 
lated development of immature stem cells, resulting 
in an increase in T-lymphocytes (17). The increase 
in T-lymphocytes may also be caused by excessive 
secretions of thymopoietin. Some of the 90% of im- 
mature T-lymphocytes or lymphoblasts which usually 
degenerate may be biochemically stimulated to ma- 
ture and become functional by exposure to the thy- 
mopoietin, increasing the number of T-lymphocytes 
in circulation. 
‘Iwo additional methods may be used to detect HIV 
infection prior to the onset of clinical symptoms: the 
Polymerase Chain Reaction (PCR) and the antibody 
binding test. The PCR test detects HIV by amplifying 
the proviral DNA sequence from mononuclear cells 
in the bloodstream. As a result of PCR test, a sin- 
gle HIV DNA molecule present in 100 00&150 000 
mononuclear cells, can be detected. From 3&50% 
of the infants who are born to HIV infected women 
become infected with HIV. Therefore, the PCR test 
may predict the presence of HIV in the bloodstream 
before immune abnormalities and/or increased levels 
of immunoglobin signify probable HIV infection (20). 
This test has detected HIV DNA over 3 months before 
immunodeliciency was expressed. Therefore, (at least 
in theory) medication may be administered prior to 
development of infectious diseases, and the immune 
system is strengthened in its resistance to HIV infec- 
tion (20,21). 
Category D-2 represents infants who have devel- 
oped recurrent bacterial infections, including menin- 
gitis, pneumonia, bone and joint infections. Category 
D-3 includes infants developing persistent and re- 
current dermal infections such as oral candidiasis, 
herpes zoster, and herpes stomatitis. The most com- 
mon symptom of this category is oral candid&is. 
The mould Candida albicans causes fungal colonies 
which macroscopically appear as white and creamy 
lesions on the stratified squamous epithelium in the 
buccal cavity (18). 
The antibody binding test uses the ELISA tech- 
nique to detect immunoglobin directed against the 
principal neutralizing domain (PND) of HIV strains. 
Absorbance levels of maternal immunoglobin de- 
creased as the concentration of the PND decreased. 
High affinity antibody is indicated by increased band 
intensity in the assay; low affinity antibody results 
in a band of lesser intensity. The affinity of antibody 
directed against the PND may therefore correlate with 
progression of the disease (22). 
Subclass E includes infants who have developed 
secondary cancers such as Kaposi’s sarcoma, primary 
lymphoma, and B-cell non-Hodgkin’s lymphoma. 
Subclass F includes infants who develop nonclini- 
cal manifestations of the HIV. Thus, these conditions 
may also be correlated with other physical abnormali- 
ties besides HIV infection such as hepatitis, cardiopa- 
thy, nephropathy, and anemia (10) (Table 2) 
The ratio of T4 helper cells to T8 cytolytic/suppre- 
ssor cells is itself indicative of the extent of immuno- 
suppression. A normal T4/r8 ratio in infants older 
than 6 months, and also in adults, is in the range of 
1.2-2.6. Therefore, T4/T8 ratios below 1.2 are consid- 
ered abnormal. Further tcs ting of the ratio is often per- 
formed for infants below the age of 6 months. How- 
ever, HIV infected infants below the age of 6 months 
have expressed T4/T8 ratios as low as 0.4 in the ab- 
sence of obvious immunosuppression (18) (Personal 
Communication, Dr Philip A Pizzo). Infants who de- 
velop immunodeficiency sequelae such as PCP, per- 
sistent diarrhea, Kaposi’s sarcoma, or other infectious 
ailments as specificied by the Center for Disease Con- 
trol, are diagnosed as suffering from AIDS (10). Detection of HIV 
It is difficult to diagnose HIV in infants imme- 
diately after parturition, because the current HIV 
tests (ELISA, Western Blot) deduce an infective 
state through detections of increased level of im- 
munoglobin G(IgG). The maternal immunoglobin re- 
mains in the infants’ bloodstream between 28-38 
days. Thus, it is indicative that the infant has been 
Mechanisms of HIV infection in infants 
Several periods both prenatally and postnatally lend 
themselves to possible mechanism of HIV infection. 
These mechanisms include 1) cross placental infec- 
tion, 2) exposure during parturation, and 3) exposure 
to fluids of the mother, primarily colostrum. Approx- 
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imately 80% of HIV infected children acquired their 
condition transplancenta.lly or perinatally (Personal 
Communication, Dr Philip A Pizzo). After 4 months 
of fetal development, the surface area of the placenta 
increases to compensate for the larger fetus. However, 
the placental barrier becomes thinner, because there 
is no increase in tissue from the uterine wall of the 
mother. Therefore, the infant’s bloodstream may be- 
come more accessible to the virus, and the virus can 
infect the appropriate cells. HIV is probably trans- 
mitted transplacentally via CD4+ receptor containing 
placental tissues: chorionic villi, the cytoplasmic cells 
in the stroma of the cytotrophoblast, or via the periph- 
eral surface of the endothelial lining of the arterioles 
and capillaries (23). However, it has also been pro- 
posed, that if viral propagation is rapidly being carried 
out, that permeability of the placenta may increase 
(24). The precise mechanism by which the HIV is 
transmitted is uncertain. HIV can infect the placental 
tissue as early as the 15th or 20th week into gestation, 
because the placental tissues become fully developed 
by the end of the first trimester (23). 
The likelihood of infection may also vary with the 
stage of gestation. During the first trimester of de- 
velopment, surface layers of the fetus are undergoing 
formation; target cells may be more accessible in the 
lirst 5 months of gestation as compared with the last 
4 months of gestation. The four layers of the der- 
mis (stratum comeum, stratum granulosum, stratum 
lucidum, and stratum germinavatum) have formed by 
the 6th month. Therefore, the probability of HIV to 
enter via the skin is minimized during the last 4 
months of gestation. Nevertheless, the fetus’ stratum 
comeum is still thinner than that of the adult’s (25). 
As a result, the remaining tissues of the periderm and 
secretions from the sebaceous glands form a dense 
and viscous protective covering known as the vemix 
caseosa. The vemix caseosa provides a temporary ex- 
tra layer to the epidermis, minimizing chances of in- 
fection through the skin in the latter stages of gesta- 
tion. 
As the fetus is expelled from the uterus and en- 
ters the vagina before expulsion, the infant’s buccal 
cavity becomes full of amniotic fluid and maternal 
blood both from cervical and vaginal secretions, and 
from tearing of tissues. Both of these fluids can con- 
tain HIV (26). Once the infant has been expelled 
from the uterus, it will attempt to ventilate its lungs; 
the infant will try to swallow. The constrictor mus- 
cles of the pharynx contract and the HIV contain- 
ing fluid enters the esophagus, which contains CD4+ 
cells (27); infection may occur. Although there have 
not been documented cases of HIV infection via the 
esophagus, the presence of Langerhans cells in the 
esophageal tissue may increase the likelihood of HIV 
infection (28). Within the skin, Langerhans cells serve 
a lymphoid function, primarily as antigen presenting 
dendritic cells. Like the T-helper cells, they also ex- 
press the CD4+ receptor (26). The mould, Candida, is 
known to enter the bloodstream via oral lesions; HIV 
may also directly enter the bloodstream through oral 
lesions (27). The infant’s swallowing of amniotic fluid 
during gestation may also theoretically be a route for 
HIV infection in the buccal cavity, esophagus, and in 
the stomach. 
Since nursing of the infant is a means of fluid trans- 
fer from the mother, several instances of infection 
of the newborn have resulted from breast feeding on 
the part of the infected mother. HTLV is thought to 
be transferred in the milk through infected T-cells 
(29); it is uncertain whether HIV can be transferred 
to the infant by free virus within the milk (30). Nor 
is the mechanism clear by which the virus actually 
penetrates the subject. The nature of conditions within 
the mouth may play a role. For example, the central 
incisors of the infant pierce through upper squamous 
epithelium approximately 6-8 months after birth. Lat- 
eral incisors arise S-10 months after birth. The upper 
layer of skin in the infant is only 0.01-0.05mm thick, 
while in the adult, the stratum comeum of the adult 
has a thickness between 0.1-0.9mm (25). It is likely 
that the infant’s skin in the buccal cavity is also thin- 
ner than in an adult. Therefore, the infant’s skin may 
not function effectively as a protective shield from the 
virus. 
Langerhans cells are heavily concentrated within 
the fissures between the infant’s deciduous teeth (17). 
In infants, epithelial cells encroach on the enamel 
of the infant’s tooth. Thus, the Langerhans cells are 
closer to the upper surface of the mouth, and they 
would have a greater probability to be infected by 
HIV. When the mother’s fluids in the form of infected 
colostrum or milk contact the buccal region, HIV in- 
fection may occur. 
The infant can also be infected with the HIV as a 
result of direct contact with the mother’s nipple and 
areola during nursing. Since the peripheral and the 
internal region of the areola is supplied with lym- 
phatic vessels, biting at the nipple and areola by the 
infant may result in the bursting of the lymph ves- 
sels. Lymph which contains infected T-helper cells 
and other appropriate cells may contact and infect 
the infant’s epithelium. Furthermore, the continuous 
suckling of the infant causes stretching of the areola, 
which in turn leads to cracking of the tissue (31). 
MANIFFSTATIONS OF PEDWRIC AIDS 
The maternal alveolar cells are the cells which se- 
crete the colostrum and the milk from the available 
fluids in the bloodstream. As the maternal infectious 
condition intensifies, the number of HIV particles also 
increases in the bloodstream. There is a greater like- 
lihood that the number of viruses that infiltrate into 
the colostrum and into the milk increases (4). 
Lymph vessels are also located in the walls of the 
lactiferous ducts. Thus, when the milk flows through 
the lactiferous ducts, the lactiferous duct may become 
distended. This may lead to microscopic rupturing of 
lymphatic vessels, and infected cells become miscible 
with the milk. The HIV within the milk is transferred 
into the buccal cavity of the infant where it can attack 
the appropriate cells. 
The infant’s stomach immediately after birth has a 
pH similar to that of the bloodstream, pH 7.4. When 
the infant begins to ingest milk and other forms of 
nutrition, oxytoxic cells begin to secrete hydrochloric 
acid. The pH in the stomach decreases to a pH be- 
tween 4 and 5, but it is a gradual process, and the pH 
would not be immediately low enough to inactivate 
the virus. As a result, the HIV could infect Langer- 
hans cells of the stomach (27), or the virus could 
spread into the duodenum, colon or rectum, all of 
which contain chromaffin cells which can be infected 
by the HIV. If the HIV reaches the anal column, it 
could be in the faecal matter or in a liquified form. 
The HIV is more likely to enter the glands in the 
anal sinuses, the external surfaces of which possesses 
lymphocytes (32). 
It is also plausible that the absorptive epithelial or 
chromaffin cells of the duodenum and colon become 
infected, and become lost from the peripheral surface 
of the intestinal mucosa. As a result, crypt cells arise 
to the peripheral surface of the intestinal mucosa to 
replace the infected chromaffin cells. However, the 
crypt cells are immature absorptive cells, and they do 
not absorb nutrients, electrolytes and other necessary 
fluids as effectively as the chromaffin cells. Thus, the 
absorption mechanism becomes resected, and loss of 
weight occurs (33). 
Bile acid diarrhea may also be a result of AIDS en- 
teropathy. The bile acids are transported to the lacteal 
vessels by a change in the electrochemical gradient 
and by active transport. However, when the absorbing 
chromaffin cells are sloughed off from the immature 
crypt cells, the bile acids are hindered from transport 
to the hepatic portal vein. Because infected infants 
have high levels of bile salts in their stool, one may 
hypothesize that the HIV affects the chromaffin cells 
of the distal ilium or small intestine where bile acid 
absorption primarily occurs (33-35). 
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As the number of women infected with HIV in- 
creases physicians will be contionted with more pe- 
diatric AIDS cases. Since there is no medication to 
completely eliminate the results of HIV infection, an 
awareness of the means by which the virus is trans- 
ferred to the fetus and/or to the infant, and the extent 
of the virus in women, would obviously lead to a 
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